Placebo 100 mg tablet, NMD670, Placebo 300 mg tablet, NMD670
NMD670-02-0001
Phase 2 small_molecule active
Quick answer
Placebo 100 mg tablet, NMD670, Placebo 300 mg tablet, NMD670 for Type 3 spinal muscular atrophy is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Type 3 spinal muscular atrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active